|
Biomarkers, imaging and safety in resmetirom 52 week non-cirrhotic NASH phase 3 clinical trial, completed open-label arm of maestro-NAFLD-1 |
|
|
|
Title: |
Biomarkers, imaging and safety in resmetirom 52 week non-cirrhotic NASH phase 3 clinical trial, completed open-label arm of maestro-NAFLD-1 |
Author: |
Harrison, Dr. S.A. Mangia, Dr. A. Lasierra-Resa, Dr. P. Cubberley, Ms. S. Taub, Dr. R.A. Neff, Dr. G.W. Alkhouri, Dr. Naim Bashir, Dr. Mustafa |
Appeared in: |
Digestive and liver disease |
Paging: |
Volume 54 () nr. S1 pages S48 |
Year: |
2022 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|